Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2) | MicrobiomeTrials← Back to trialsNCT04141631
Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)
CompletedNAINTERVENTIONAL
Trial Details
Start: 2020-01-13Est. Completion: 2022-05-10
Enrollment target: 128 participants Locations- DEpartement d'anesthésie et réanimation D - Arnaud de Villeneuve, Montpellier, France
Other microbiome trials you might be interested in
Photobiomodulation TherapyPhotomedicineLow-Level Laser TherapyPerformance EnhancementQuadricepsSpecial Operations Readiness
Special Operations Forces (SOF) train continually to maintain peak performance. Thus, they are nearly always in a state …
Joint Base Lewis McChord, United StatesCompleted Mar 2, 2026
Older AdultsHip Fracture SurgeryFascia Iliaca BlockLiposomal Bupivacaine
Postoperative Pain
Older patients with hip fractures often suffer from severe pain. Inadequate analgesia increases the risk of postoperativ…
Beijing, ChinaEst. completion Jun 2028
Atrial Fibrillation (AF)Cardiac ArrhythmiaAtrial Fibrillation AblationBDNFAtrial Cardiomyopathy
trial fibrillation (AF) is the most common cardiac arrhythmia worldwide, and its prevalence continues to rise. AF is ass…
Dijon, FranceEst. completion Jul 2029